Literature DB >> 9639

Implications of cross inhibitory interactions of potential mediators of hormone and neurotransmitter action.

E Van Cauter, J G Hardman, J E Dumont.   

Abstract

Mediators of hormone and neurotransmitter action may exert negative control on the accumulation of one another (adenosine 3':5'-cyclic monophosphate, or conversely). A model in which one agonist stimulates the formation of two mediators which inhibit each other's accumulation has been simulated. Three types of agonist-receptor interaction, five mechanisms of inhibition, and three types of basal activity have been considered which lead to a set of 45 descriptions of the general cross inhibition model. For these submodels, pattern of the relation of agonist to mediator concentrations at steady state conditions have been defined. Some patterns are complex with mediator curves exhibiting extrema, one a maximum and the other a minimum. The complexity of the pattern depends on the submodel and on the degree of asymmetry between the parameters of each of the mediator pathways (e.g.,affinities for the agonist, strength of the inhibitions, etc.). This simple model can thus account for complex experimental results without requiring the postulation of elaborate molecular models of agonist-receptor interaction. The simulations presented emphasize the necessity of investigating a wide range of agonist concentrations.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9639      PMCID: PMC430901          DOI: 10.1073/pnas.73.9.2982

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  The control of adenylate cyclase by calcium in turkey erythrocyte ghosts.

Authors:  M L Steer; A Levitzki
Journal:  J Biol Chem       Date:  1975-03-25       Impact factor: 5.157

Review 2.  Control of calcium transport in the myocardium by the cyclic AMP-Protein kinase system.

Authors:  A M Katz; M Tada; M A Kirchberger
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Control and role of cyclic 3',5'-guanosine monophosphate.

Authors:  J Van Sande; C Decoster; J E Dumont
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

4.  Cyclic nucleotides and the contraction of smooth muscle.

Authors:  R Andersson; K Nilsson; J Wikberg; S Johansson; E Mohme-Lundholm; L Lundholm
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

Review 5.  Cyclic nucleotides and cellular calcium metabolism.

Authors:  H Rasmussen; P Jensen; W Lake; N Friedmann; D B Goodman
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

6.  The role of calcium and cyclic nucleotides in alpha-amylase release from slices of rat parotid: studies with the divalent cation ionophore A-23187.

Authors:  F R Butcher
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

7.  The role of cyclic GMP in the regulation of cyclic AMP hydrolysis.

Authors:  W L Terasaki; M M Appleman
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

8.  Bioregulation of lysosomal enzyme secretion from human neutrophils: roles of guanosine 3':5'-monophosphate and calcium in stimulus-secretion coupling.

Authors:  R J Smith; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

Review 9.  Thyroid-stimulating hormone and cyclic adenosine 3',5'-monophosphate in the regulation of thyroid gland function.

Authors:  J B Field
Journal:  Metabolism       Date:  1975-03       Impact factor: 8.694

10.  Control of cardiac sarcolemmal adenylate cyclase and sodium, potassium-activated adenosinetriphosphatase activities.

Authors:  M Tada; M A Kirchberger; J M Iorio; A M Katz
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

View more
  1 in total

1.  Ubiquitin ligase switch in plant photomorphogenesis: A hypothesis.

Authors:  Alexandra Pokhilko; Jason A Ramos; Hans Holtan; Don R Maszle; Rajnish Khanna; Andrew J Millar
Journal:  J Theor Biol       Date:  2010-11-18       Impact factor: 2.691

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.